Schepens Eye Research Institute
Boston, Massachusetts, 02114, United States
Location status: Recruiting
NCT Number: NCT04424979
The investigators will develop and test different configurations of high-power prisms to expand the field of vision of patients with visual field loss to assist them with obstacle detection when walking. The study will involve multiple visits (typically four) to Schepens Eye Research Institute for fitting and testing with the prism glasses. The overall objective is to determine best designs and fitting parameters for implementation in prism devices for future clinical trials.
Interested in participating?
Request Info7 year–80 year
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02114, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
High power prisms designed to shift images from blind areas into portions of the wearer's remaining, seeing, field of vision
Time frame: Through study completion, an average of four months
Horizontal and vertical extent of the expansion (in degrees) of the field of view
Time frame: Through study completion, an average of four months
Proportion of pedestrians detected (in simulated walking or simulated driving)
Contact information is provided by the study sponsor or research team.
Massachusetts Eye and Ear Infirmary
Other
Visual Field Expansion Through Innovative Multi-Periscopic Prism Design
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06047717
Blindness, Brain Diseases
Rochester, New York, United States
View Trial DetailsNCT06578117
Blindness, Brain Diseases
Rochester, New York, United States
View Trial DetailsNCT06638619
Blindness, Brain Diseases
View Trial DetailsNCT05894434
Blindness, Blindness, Cortical
Winston-Salem, North Carolina, United States
View Trial Details